ZIGExN (3679) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 Nov, 2025Executive summary
FY2025 revenue reached ¥25.45 billion, up 9–9.5% YoY, with EBITDA of ¥7.08 billion and operating profit of ¥5.66 billion, all at record highs and slightly exceeding revised forecasts.
Growth was driven by strong performance in Vertical HR (notably Ties and Awesome Agent), successful PMI, and contributions from small- to mid-sized M&A, while Living Tech and Life Service faced macroeconomic headwinds.
Shareholder returns included a record-high dividend of ¥10.5 per share, a ¥700 million share buyback cap, and the introduction of a shareholder benefit program; financial policy was revised for greater flexibility.
Cash and cash equivalents increased by ¥1.05 billion to ¥14.3 billion at year-end.
Financial highlights
Revenue: ¥25.45 billion (+9–9.5% YoY); EBITDA: ¥7.08 billion (+4–4.5% YoY); operating profit: ¥5.66 billion (+4.9–5% YoY); net income: ¥3.87 billion (+1.9–2% YoY); EPS: ¥38.13 (+4% YoY).
All key metrics achieved or exceeded revised forecasts, with revenue and profit both at 101–102% of targets.
Operating cash flow reached a record ¥7.31 billion; investing activities used ¥2.45 billion, and financing activities used ¥3.84 billion.
Corporate client count rose 4.1% YoY to 23,177; average client spend up 5.2% YoY to ¥1.1 million.
Goodwill-to-equity ratio at 0.5x; equity ratio at 53.2%.
Outlook and guidance
FY2026 guidance: revenue ¥28 billion (+10% YoY), EBITDA ¥7.43 billion (+5% YoY), operating profit ¥5.88 billion (+4% YoY), net income ¥4.02 billion (+3.8–4% YoY), EPS ¥40.20 (+5% YoY).
Dividend forecast raised to ¥11.0 per share for FY2026.
Growth expected to be led by Vertical HR and Living Tech, with continued focus on PMI, M&A, and product improvements; profit margins projected conservatively due to business investments and non-core impacts.
Latest events from ZIGExN
- Revenue and net income up YoY, with strong HR growth and higher dividends forecast.3679
Q3 20269 Feb 2026 - Q2 revenue up 12.3% YoY, record profits, strong HR, and robust progress toward annual targets.3679
Q2 202611 Nov 2025 - Record Q1 revenue and EBITDA, but net income declined slightly; outlook unchanged.3679
Q1 202612 Aug 2025 - Record Q1 growth and improved margins support unchanged full-year guidance.3679
Q1 202513 Jun 2025 - Double-digit Q2 growth, strong core segments, and higher shareholder returns.3679
Q2 202513 Jun 2025 - Revenue up 10% YoY, outlook revised down, shareholder returns enhanced.3679
Q3 20259 Jun 2025